This mini case study review article is the third in a series exploring tumour necrosis factor (TNF) inhibitors in the treatment of immune-mediated disease. This article explores anti-TNF therapies, which are generally considered to be an effective, well-tolerated treatment option for the management of chronic conditions related to the overproduction of TNF-α.
EMJ Gastroenterology 11 [Supplement 7] . 2022
November 2022
In this issue
Latest articles
All articles![](https://www.emjreviews.com/wp-content/uploads/2024/03/NCA-What-is-PEAL-Syndrome-Gast-940x564.png)
![](https://www.emjreviews.com/wp-content/uploads/2023/11/Is-Intestinal-Cell-Death-in-Necrotising-Enterocolitis-Assorted-and-Multifarious-940x564.png)
![](https://www.emjreviews.com/wp-content/uploads/2023/11/Gastro_CaseReport_SAPHO-Syndrome-in-Crohns-Disease-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2023/11/Gideon-Hirschfield-940x564.png)